Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Common Stock, par value $0.004 per share ("Shares")
-
Shares outstanding
-
22,866,677
-
Total 13F shares
-
23,558,818
-
Share change
-
+39,837
-
Total reported value
-
$498,895,905
-
Put/Call ratio
-
18%
-
Price per share
-
$21.27
-
Number of holders
-
89
-
Value change
-
-$47,151,037
-
Number of buys
-
50
-
Number of sells
-
30
Institutional Holders of BICYCLE THERAPEUTICS PLC - Common Stock, par value $0.004 per share ("Shares") (BCYC) as of Q1 2023
As of 31 Mar 2023,
BICYCLE THERAPEUTICS PLC - Common Stock, par value $0.004 per share ("Shares") (BCYC) was held by
89 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
23,558,818 shares.
The largest 10 holders included
Deep Track Capital, LP, Jefferies Financial Group Inc., Paradigm Biocapital Advisors LP, MORGAN STANLEY, JANUS HENDERSON GROUP PLC, TYBOURNE CAPITAL MANAGEMENT (HK) LTD, Candriam S.C.A., Polar Capital Holdings Plc, Sio Capital Management, LLC, and BAKER BROS. ADVISORS LP.
This page lists
89
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.